Myriad Genetics Inc
NASDAQ:MYGN

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
NASDAQ:MYGN
Watchlist
Price: 22.22 USD -2.42% Market Closed
Market Cap: 2B USD
Have any thoughts about
Myriad Genetics Inc?
Write Note

Myriad Genetics Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Myriad Genetics Inc
Total Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Myriad Genetics Inc
NASDAQ:MYGN
Total Receivables
$117.8m
CAGR 3-Years
8%
CAGR 5-Years
-3%
CAGR 10-Years
3%
Abbvie Inc
NYSE:ABBV
Total Receivables
$11.7B
CAGR 3-Years
6%
CAGR 5-Years
16%
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Total Receivables
$4.7B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Receivables
$6.9B
CAGR 3-Years
16%
CAGR 5-Years
13%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Receivables
$1.7B
CAGR 3-Years
21%
CAGR 5-Years
29%
CAGR 10-Years
35%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Receivables
$5.7B
CAGR 3-Years
-7%
CAGR 5-Years
18%
CAGR 10-Years
20%

See Also

What is Myriad Genetics Inc's Total Receivables?
Total Receivables
117.8m USD

Based on the financial report for Jun 30, 2024, Myriad Genetics Inc's Total Receivables amounts to 117.8m USD.

What is Myriad Genetics Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
3%

Over the last year, the Total Receivables growth was 5%. The average annual Total Receivables growth rates for Myriad Genetics Inc have been 8% over the past three years , -3% over the past five years , and 3% over the past ten years .

Back to Top